Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00322985
Status:
COMPLETED
Last Update Posted:
2016-03-16
First Post:
2006-05-05
Brief Title:
A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkins Lymphoma
Sponsor:
AHS Cancer Control Alberta
Organization:
AHS Cancer Control Alberta
Organization Data
Organization:
AHS Cancer Control Alberta
Class:
OTHER
Study ID:
22409
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AHS Cancer Control Alberta
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Celgene Corporation | INDUSTRY |
| Alberta Cancer Foundation | OTHER |